White House Deal Making Moves into Biotech with a Recent Bid to Secure Exclusive Rights to COVID-19 Vaccine from Germany

President Donald Trump invited a German-based biotech venture, CureVac, to the White House to make a deal earlier this month. As it turns out, CureVac does research and development into the coronavirus differently and may be on to something powerful, involving a novel...

Pin It on Pinterest